Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats.

Psychopharmacology
Yonghui LiGilbert J Kirouac

Abstract

Anatomical studies have shown that the paraventricular nucleus of the thalamus (PVT) innervates areas of the forebrain involved in the expression and regulation of emotional behaviors including fear and anxiety. In addition, the PVT is densely innervated by fibers containing orexin-A (OXA) and orexin-B (OXB), peptides that are well-known for their arousal effects on behavior. In this study, we investigate whether microinjections of orexin receptor agonists and antagonists in the PVT region alter expression of anxiety-like behaviors in the rat as measured in the elevated plus maze. We report that microinjections of OXA and OXB in the PVT region elicited anxiety-like response as indicated by a reduction in open arm time and entries. In addition, OXA and OXB produced changes in ethological measures indicative of an anxiety state. Central administrations of antagonists for corticotropin releasing factor (CRF) or the opioid kappa receptors attenuated the anxiogenic effects produced by microinjections of OXA in the PVT region. We also provide evidence that endogenously released orexins act at the PVT to produce anxiety by showing that microinjections of TCSOX229, an orexin-2 receptor antagonist, in the PVT region attenuated the anxio...Continue Reading

References

Jul 1, 1992·Physiological Reviews·B M SpruijtW H Gispen
Feb 1, 1994·Trends in Neurosciences·H J Groenewegen, H W Berendse
Sep 1, 1994·Pharmacology, Biochemistry, and Behavior·A P CruzF G Graeff
Oct 1, 1995·Pharmacology, Biochemistry, and Behavior·R J Rodgers, N J Johnson
Mar 1, 1997·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R J RodgersA Holmes
Oct 23, 1997·Behavioural Brain Research·E F Espejo
Jan 7, 1998·Neuroscience and Biobehavioral Reviews·R J Rodgers, A Dalvi
Mar 10, 1998·Neuroscience and Biobehavioral Reviews·A Ramos, P Mormède
Mar 29, 2000·Biochemical and Biophysical Research Communications·T IdaN Murakami
Dec 7, 2000·Journal of Neuroendocrinology·M JászberényiG Telegdy
May 23, 2001·The Journal of Comparative Neurology·J N MarcusJ K Elmquist
Dec 18, 2001·The Journal of Comparative Neurology·E Timofeeva, D Richard
May 30, 2002·Neuroscience and Biobehavioral Reviews·Rudolf N CardinalBarry J Everitt
Jun 8, 2002·Annual Review of Neuroscience·Shahrad TaheriEmmanuel Mignot
Jul 9, 2002·Brain Research·Rodrigo A EspañaCraig W Berridge
Nov 27, 2002·Neuropeptides·R J RodgersJ E Blundell
Feb 26, 2003·European Journal of Pharmacology·S Mechiel Korte, Sietse F De Boer
Feb 26, 2003·European Journal of Pharmacology·David L WalkerMichael Davis
May 9, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Andrew J ThorpeCatherine M Kotz
Dec 4, 2003·Bioorganic & Medicinal Chemistry Letters·Masaaki HiroseKoji Yamada
Jan 28, 2004·Annual Review of Psychology·Jerome M Siegel
Aug 7, 2004·The Journal of Pharmacology and Experimental Therapeutics·Stephen C Heinrichs, George F Koob

❮ Previous
Next ❯

Citations

May 18, 2012·Psychopharmacology·Michel A SteinerFrancois Jenck
Feb 4, 2014·Psychoneuroendocrinology·David H ArendtCliff H Summers
Aug 21, 2013·Brain Structure & Function·Xiaoyu ChenGilbert J Kirouac
Sep 29, 2011·Cellular and Molecular Life Sciences : CMLS·Nathan J MarchantGavan P McNally
Aug 11, 2015·Neuroscience and Biobehavioral Reviews·Gilbert J Kirouac
Oct 11, 2011·Peptides·Richard J Bodnar
Jul 29, 2015·Trends in Neurosciences·África FloresFernando Berrendero
Jul 22, 2014·Medicinal Research Reviews·Quanhui ChenDong Gao
Sep 13, 2013·Progress in Neurobiology·Jean-Christophe CasselRobert P Vertes
Jan 3, 2012·Pharmacology, Biochemistry, and Behavior·Anne E Panhelainen, Esa R Korpi
Apr 7, 2015·Journal of Chemical Neuroanatomy·Sarah Sulaiman Ch'ng, Andrew J Lawrence
Apr 2, 2014·Frontiers in Behavioral Neuroscience·Yonghui LiGilbert J Kirouac
Aug 8, 2014·Frontiers in Behavioral Neuroscience·Morgan H JamesChristopher V Dayas
Mar 22, 2014·Frontiers in Behavioral Neuroscience·David T HsuSeema Bhatnagar
Aug 23, 2016·Current Biology : CB·J Antonio GonzálezDenis Burdakov
Aug 31, 2016·Behavioural Brain Research·Huiying WangGilbert J Kirouac
Oct 16, 2016·Fundamental & Clinical Pharmacology·Elham Kordi JazAli Roohbakhsh
Jun 17, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·África FloresFernando Berrendero
Jul 4, 2018·Alcoholism, Clinical and Experimental Research·Anuranita GuptaJessica R Barson
Sep 18, 2010·The International Journal of Neuropsychopharmacology·Nanxin LiShuchang He
Oct 5, 2012·American Journal of Physiology. Cell Physiology·Jyrki P Kukkonen
Aug 20, 2016·The Journal of Pharmacology and Experimental Therapeutics·Alessandra MatzeuRémi Martin-Fardon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.